MyFinsight
Home
About
Contact
zbio: the income statement
Download
Download image
Comprehensive loss
-$51,474K
(-33.16%↓ Y/Y)
Unrealized gain on
investments
$35K
Foreign currency
translation adjustment
-$10K
(80.00%↑ Y/Y)
Net loss to common
stockholders
-$51,499K
(-33.40%↓ Y/Y)
Other income, net
$1,081K
(-54.54%↓ Y/Y)
Loss before income
taxes
-$51,499K
Total other income
(expense), net
$1,081K
(-54.54%↓ Y/Y)
Loss from operations
-$52,580K
(-28.29%↓ Y/Y)
Total operating
expenses
$52,580K
(28.29%↑ Y/Y)
Acquired in-process
research and development
$5,000K
General and
administrative
$13,178K
(76.79%↑ Y/Y)
Research and development
$34,402K
(2.60%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)